SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Norris Medicines informs about newspaper publication

10 Sep 2024 Evaluate
Pursuant to Regulation 47 and 30 read with schedule III of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, in connection with, the 33rd Annual General Meeting of Norris Medicines, to be held on Monday 30th September, 2024 at 12.00 PM through Video Conferencing /Other Audio-Visual means, Norris Medicines has attached copies of newspaper advertisement published on Thursday, 05th September, 2024 as Pre-Dispatch of Notice of AGM and advertisement published on Tuesday, 10th September, 2024 as Post-Dispatch of Notice of AGM & Annual Report for the Financial Year 2023-2024 to the shareholders, E-Voting Information and Notice of Book Closure.

The above information is a part of company’s filings submitted to BSE.

Norris Medicines Share Price

14.22 -0.02 (-0.14%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×